A model for predicting size distributions delivered from pMDIs with suspended drug

Stephen W. Stein, Poonam Sheth, Paul B Myrdal

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A new model has been developed for predicting size distributions delivered from pressurized metered dose inhalers (pMDIs) that contain suspended drug particles. This model enables the residual particle size distribution to be predicted for a broad range of formulations. It expands on previous models by allowing for polydisperse micronized input drug, multiple suspended drugs, dissolved drug, and dissolved or suspended excipient to be included in the formulation. The model indicates that for most pMDI configurations, the majority of droplets contain no drug or a single drug particle and the residual particle size distribution delivered from the pMDI is essentially equivalent to the size distribution of the micronized drug used in the formulation. However, for pMDIs with a high drug concentration or that use small micronized drug particles, there can be a substantial fraction of the droplets that contain multiple drug particles. The residual particle size distribution obtained from these pMDIs can be substantially larger than the size distribution of the micronized drug. Excellent agreement was observed between size distributions predicted using this model and those obtained from experimental cascade impactor measurements (r 2 = 0.97), thus demonstrating the ability of the model to accurately predict the size distributions obtained from suspension pMDIs.

Original languageEnglish (US)
Pages (from-to)101-115
Number of pages15
JournalInternational Journal of Pharmaceutics
Volume422
Issue number1-2
DOIs
StatePublished - Jan 17 2012

Fingerprint

Metered Dose Inhalers
Pharmaceutical Preparations
Particle Size
Excipients
Suspensions

Keywords

  • Aerodynamic particle size
  • Pressurized metered dose inhaler (pMDI)
  • Simulation model
  • Suspension formulation

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

A model for predicting size distributions delivered from pMDIs with suspended drug. / Stein, Stephen W.; Sheth, Poonam; Myrdal, Paul B.

In: International Journal of Pharmaceutics, Vol. 422, No. 1-2, 17.01.2012, p. 101-115.

Research output: Contribution to journalArticle

@article{192ea281bde145168016e0ff49c0cedc,
title = "A model for predicting size distributions delivered from pMDIs with suspended drug",
abstract = "A new model has been developed for predicting size distributions delivered from pressurized metered dose inhalers (pMDIs) that contain suspended drug particles. This model enables the residual particle size distribution to be predicted for a broad range of formulations. It expands on previous models by allowing for polydisperse micronized input drug, multiple suspended drugs, dissolved drug, and dissolved or suspended excipient to be included in the formulation. The model indicates that for most pMDI configurations, the majority of droplets contain no drug or a single drug particle and the residual particle size distribution delivered from the pMDI is essentially equivalent to the size distribution of the micronized drug used in the formulation. However, for pMDIs with a high drug concentration or that use small micronized drug particles, there can be a substantial fraction of the droplets that contain multiple drug particles. The residual particle size distribution obtained from these pMDIs can be substantially larger than the size distribution of the micronized drug. Excellent agreement was observed between size distributions predicted using this model and those obtained from experimental cascade impactor measurements (r 2 = 0.97), thus demonstrating the ability of the model to accurately predict the size distributions obtained from suspension pMDIs.",
keywords = "Aerodynamic particle size, Pressurized metered dose inhaler (pMDI), Simulation model, Suspension formulation",
author = "Stein, {Stephen W.} and Poonam Sheth and Myrdal, {Paul B}",
year = "2012",
month = "1",
day = "17",
doi = "10.1016/j.ijpharm.2011.10.035",
language = "English (US)",
volume = "422",
pages = "101--115",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A model for predicting size distributions delivered from pMDIs with suspended drug

AU - Stein, Stephen W.

AU - Sheth, Poonam

AU - Myrdal, Paul B

PY - 2012/1/17

Y1 - 2012/1/17

N2 - A new model has been developed for predicting size distributions delivered from pressurized metered dose inhalers (pMDIs) that contain suspended drug particles. This model enables the residual particle size distribution to be predicted for a broad range of formulations. It expands on previous models by allowing for polydisperse micronized input drug, multiple suspended drugs, dissolved drug, and dissolved or suspended excipient to be included in the formulation. The model indicates that for most pMDI configurations, the majority of droplets contain no drug or a single drug particle and the residual particle size distribution delivered from the pMDI is essentially equivalent to the size distribution of the micronized drug used in the formulation. However, for pMDIs with a high drug concentration or that use small micronized drug particles, there can be a substantial fraction of the droplets that contain multiple drug particles. The residual particle size distribution obtained from these pMDIs can be substantially larger than the size distribution of the micronized drug. Excellent agreement was observed between size distributions predicted using this model and those obtained from experimental cascade impactor measurements (r 2 = 0.97), thus demonstrating the ability of the model to accurately predict the size distributions obtained from suspension pMDIs.

AB - A new model has been developed for predicting size distributions delivered from pressurized metered dose inhalers (pMDIs) that contain suspended drug particles. This model enables the residual particle size distribution to be predicted for a broad range of formulations. It expands on previous models by allowing for polydisperse micronized input drug, multiple suspended drugs, dissolved drug, and dissolved or suspended excipient to be included in the formulation. The model indicates that for most pMDI configurations, the majority of droplets contain no drug or a single drug particle and the residual particle size distribution delivered from the pMDI is essentially equivalent to the size distribution of the micronized drug used in the formulation. However, for pMDIs with a high drug concentration or that use small micronized drug particles, there can be a substantial fraction of the droplets that contain multiple drug particles. The residual particle size distribution obtained from these pMDIs can be substantially larger than the size distribution of the micronized drug. Excellent agreement was observed between size distributions predicted using this model and those obtained from experimental cascade impactor measurements (r 2 = 0.97), thus demonstrating the ability of the model to accurately predict the size distributions obtained from suspension pMDIs.

KW - Aerodynamic particle size

KW - Pressurized metered dose inhaler (pMDI)

KW - Simulation model

KW - Suspension formulation

UR - http://www.scopus.com/inward/record.url?scp=84655176372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84655176372&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2011.10.035

DO - 10.1016/j.ijpharm.2011.10.035

M3 - Article

VL - 422

SP - 101

EP - 115

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -